Nanotechnology
Researchers at ITMO University in Russia have developed a systematic approach to designing gold nanoparticles for targeted drug delivery using density functional theory (DFT). The approach has shown promising results in predicting binding energies and elucidating electronic properties of AuNP-drug complexes. According to the study, the use of DFT has
Nanotechnology
A new research study aimed to develop and evaluate dual-responsive magnetic and pH-sensitive beads for controlled cisplatin delivery to glioblastoma cell lines. The study, conducted by researchers at Kerman University of Medical Sciences in Iran, involved synthesizing cobalt ferrite nanoparticles using a green co-precipitation method and incorporating them into sodium
Nanotechnology
New research emerging from Beijing, People's Republic of China, has shed light on the potential of biomembrane-derived nanoparticles in addressing bone aging diseases, such as osteoporosis and osteoarthritis. These conditions pose significant health challenges, particularly in countries experiencing demographic aging. Conventional treatment strategies often yield suboptimal therapeutic outcomes
Nanotechnology
Research by Ganpat University explores the potential of pectin-based nanoparticles in cancer treatment, highlighting their role as a promising biomaterial in nanoparticle formulation. The review discusses the structure, properties, and extraction methods of pectin, its biocompatibility and biodegradability, and various targeting strategies for overcoming biological barriers. The research examines the
Nanotechnology
Researchers at Ludwig-Maximilians-Universitat Munchen have made a significant breakthrough in cancer gene therapy by developing synthetic nanoparticles that can deliver nucleic acids to target EMT-phenotypic breast cancer cells. The study, funded by the Bundesministerium fur Bildung und Forschung, aimed to create a nanoparticulate delivery vehicle that targets CD44, a transmembrane
Nanotechnology
Researchers at Graphic Era Hill University in Dehradun, India, have explored the potential of biotinylated nanoparticles in targeted cancer therapy. By leveraging biotin's high affinity for biotin receptors on cancerous cells, these nanoparticles achieve selective targeting, leading to enhanced drug bioavailability and cellular uptake. The review article, published
Nanotechnology
Research at the Federal University of Juiz de Fora has highlighted the potential of poly(lactic-glycolic acid) (PLGA) nanoparticles in enhancing pulmonary drug delivery. The study emphasizes the need for more effective therapeutic approaches to combat pulmonary diseases, such as asthma, tuberculosis, and lung cancer, which are increasingly prevalent due
Nanotechnology
Researchers at Harbin Medical University Cancer Hospital have made significant strides in developing a targeted nanomedicine to address abdominal aortic aneurysm (AAA) growth and prevent rupture. The innovative treatment utilizes tea polyphenol nanoparticles as carriers for doxycycline, which is specifically targeted to AAA lesions. This nanomedicine demonstrates remarkable 5-fold accumulation
Nanotechnology
Researchers at the University Medical Center Utrecht, Netherlands, have been studying the effects of protein corona formation on nanoparticles, specifically lipid nanoparticles (LNPs), used in drug delivery research. The team's findings, published in the Beilstein Journal of Nanotechnology, highlight the importance of understanding how protein corona formation affects
Nanotechnology
Researchers in China have developed a new method for preparing albumin nanoparticles, which have shown potential in improving the anti-breast cancer efficacy of a natural compound called baicalin. The study, published in the International Journal of Biological Macromolecules, aimed to create a novel nanodrug delivery system that could overcome the
Nanoparticles
The global lipid nanoparticles market, driven by a robust biopharmaceutical R&D landscape and regulatory backing, is expected to reach $2.89 billion by 2032, growing at a compound annual growth rate (CAGR) of 14.15% during the forecast period 2024-2032. The U.S. lipid nanoparticles market size was
Nanoparticles
Researchers at the University of Milan have discovered a new application for cannabigerol (CBG), a non-psychoactive phytocannabinoid, in the development of nanoparticles for targeted cancer therapy. CBG-based nanoparticles have shown to exhibit antiproliferative activity, indicating their potential as a versatile nanomedicine platform for cancer treatment. Key Takeaways: * The researchers conjugated
